BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15149624)

  • 21. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications.
    Dejaegher B; Heyden YV
    J Pharm Biomed Anal; 2011 Sep; 56(2):141-58. PubMed ID: 21632194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of parallel chemistry in drug discovery.
    Edwards PJ
    IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in multivariate analysis in pharmaceutical process development.
    McKay B; Hoogenraad M; Damen EW; Smith AA
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):966-77. PubMed ID: 14758764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'One bead two compound libraries' for detecting chemical and biochemical conversions.
    Meldal M
    Curr Opin Chem Biol; 2004 Jun; 8(3):238-44. PubMed ID: 15183321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 27. Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research.
    Greis KD
    Mass Spectrom Rev; 2007; 26(3):324-39. PubMed ID: 17405133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic overview of chemoinformatics.
    Engel T
    J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial biosynthesis for drug development.
    Menzella HG; Reeves CD
    Curr Opin Microbiol; 2007 Jun; 10(3):238-45. PubMed ID: 17553731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution-phase library generation: methods and applications in drug discovery.
    Gayo LM
    Biotechnol Bioeng; 1998; 61(2):95-106. PubMed ID: 10099503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 34. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-phase compound library synthesis in drug design and development.
    Edwards PJ; Morrell AI
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):594-605. PubMed ID: 12197317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of microwave-assisted organic synthesis in drug discovery.
    Mavandadi F; Pilotti A
    Drug Discov Today; 2006 Feb; 11(3-4):165-74. PubMed ID: 16533715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lab-on-a-chip: microfluidics in drug discovery.
    Dittrich PS; Manz A
    Nat Rev Drug Discov; 2006 Mar; 5(3):210-8. PubMed ID: 16518374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Software for rapid prototyping in the pharmaceutical and biotechnology industries.
    Kappler MA
    Curr Opin Drug Discov Devel; 2008 May; 11(3):389-92. PubMed ID: 18428093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A decade of fragment-based drug design: strategic advances and lessons learned.
    Hajduk PJ; Greer J
    Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.